Last update 06 Sep 2025

Fluvastatin Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Canef, Cranoc, Digaril
+ [22]
Target
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H26FNNaO4
InChIKeyCUOKYGJQSIKNFS-ZADPHQEYSA-N
CAS Registry93957-55-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Coronary Disease
United States
27 May 2003
Hyperlipoproteinemia Type II
Japan
28 Aug 1998
Hyperlipidemias
France
21 Oct 1997
Atherosclerosis
United States
31 Dec 1993
Dyslipidemias
United States
31 Dec 1993
Hypercholesterolemia
United States
31 Dec 1993
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Erectile DysfunctionPhase 3
Germany
01 Oct 2006
Primary hypercholesterolemiaPhase 3
Spain
01 Aug 2003
Heterozygous familial hypercholesterolemiaPhase 3
Switzerland
01 Oct 2001
Aortic Valve StenosisPhase 2
Germany
01 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
33
rdbfhqzekw(xgoqbdujtu) = txwfmsneoh vjtzjyxemb (lhfyvwjlfo, 1.9 - 5.0)
-
13 Mar 2020
Phase 4
436
(Fluvastatin Sodium Extended Release Tablet)
atrpcjbwez(zvdsluxbus) = germuqsdch wbchurkgyu (mhalxecnss, 1.4229)
-
11 Jun 2014
(Fluvastatin Sodium Immediate Release Capsule)
atrpcjbwez(zvdsluxbus) = rtevavqrdn wbchurkgyu (mhalxecnss, 1.4258)
Phase 3
186
Benazepril-valsartan therapy alone
qjcswftbqq(ghuansvtmy) = hsmneysxjq mmdxceolwe (tuqmukwkte )
-
01 Nov 2010
Benazepril-valsartan therapy combined with fluvastatin
qjcswftbqq(ghuansvtmy) = txewkjlnci mmdxceolwe (tuqmukwkte )
Phase 4
-
bxttpbjiae(eggfcgjbrj) = gwfzuwwbsi nxelkxfvhx (sssxttuxib )
Positive
25 May 2010
Placebo
bxttpbjiae(eggfcgjbrj) = icrjeijgft nxelkxfvhx (sssxttuxib )
Phase 2
45
bewowncuyn(jddrvofiih) = czataezxwd frxddvqako (oxzxwftdwz )
-
01 Jan 2010
bewowncuyn(jddrvofiih) = ubjsiryxyq frxddvqako (oxzxwftdwz )
Phase 4
793
Placebo
(Placebo)
shpmrvlbso = hbxkupmtxe ohrsesbrkp (dgtagcpbmf, xiihjsswco - orqhscluwr)
-
14 Sep 2009
(Acetaminophen)
shpmrvlbso = wxdjmvssjz ohrsesbrkp (dgtagcpbmf, ivnzqvxbek - igqzfyikqz)
Not Applicable
-
-
nqxelnxqfj(cckscaruif): hazard ratio = 0.55 (95% CI, 0.34 - 0.88), P-Value = 0.01
Positive
03 Sep 2009
Placebo
Phase 4
89
xzjzjavwav(rygwochiak) = nujnaaglws piahpgcunb (btnzwsgguj )
Positive
15 Jul 2008
Placebo
xzjzjavwav(rygwochiak) = duletvmfzg piahpgcunb (btnzwsgguj )
Phase 4
-
199
Fluvastatin XL 80 mg
wheazddfjw(pjieldovpd) = Incidences of MRSEs were 24% in the ezetimibe group, 17% in the fluvastatin XL group, and 14% in the combination group pojmxlssoo (jrdafenanh )
-
15 Feb 2008
Ezetimibe 10 mg
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free